As of December 31, 2025, the Company measured the following assets and liabilities at fair value (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Recurring Basis: | | | | | | | | | | Real estate equity securities | | $ | 46,773 | | | $ | 46,773 | | | $ | — | | | $ | — | | | Asset derivatives - interest rate swaps | | 764 | | | — | | | 764 | | | — | | | | | | | | | | | | Liability derivatives - interest rate swaps | | (407) | | | — | | | (407) | | | — | |
During the year ended December 31, 2025, the Company measured the following assets at fair value on a nonrecurring basis (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Nonrecurring Basis: | | | | | | | | | Impaired real estate (1) | | $ | 343,100 | | | $ | — | | | $ | — | | | $ | 343,100 | | _____________________ (1) Amount represents the fair value for real estate assets impacted by an impairment charge during the year ended December 31, 2025, as of the date that the fair value measurement was made, which was September 30, 2025. The carrying value for the real estate assets measured at a reporting date other than September 30, 2025 may have subsequently increased or decreased from the fair value reflected due to activity that has occurred since the measurement date.
|